|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/42 | |
| A61P 35/00 | |||
| A61K 31/353 | |||
| A61K 31/44 | |||
| A61K 31/496 | |||
| A61K 45/06 |
| (11) | Number of the document | 3253208 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16747066.5 |
| Date of filing the European patent application | 2016-02-01 | |
| (97) | Date of publication of the European application | 2017-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/016008 |
| Date | 2016-02-01 |
| (87) | Number | WO 2016/126618 |
| Date | 2016-08-11 |
| (30) | Number | Date | Country code |
| 201562111030 P | 2015-02-02 | US |
| (72) |
GOLD, Daniel P., US
QUINTELA-FANDINO, Miguel, ES
|
| (73) |
MEI Pharma, Inc.,
11455 El Camino Real, Suite 250, San Diego, CA 92130,
US
The Spanish National Cancer Research Centre, Melchor Fernandez Almagro 3, 28029 Madrid, ES |
| (54) | COMBINATION THERAPIES FOR USE IN THE TREATMENT OF BREAST CANCER |
| COMBINATION THERAPIES FOR USE IN THE TREATMENT OF BREAST CANCER |